AORT Artivion, Inc.

$21.18 -0.21%

Healthcare · Surgical & Medical Instruments & Apparatus

Artivion, Inc. (AORT) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $1.0 billion. Shares last traded at $21.18, 56.1% below their 52-week high. Over the past year the stock is down 29.0%. AORT trades at a price-to-earnings ratio of 105.23, above the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 2.2%, above the peer median of -7.6%. Revenue grew 13.6% year over year. The shares yield 1.1% in dividends.

Market Cap

$1.0B

Shares Out

48.5M

EPS (TTM)

$0.20

P/E Ratio

105.88

P/S Ratio

2.33

P/B Ratio

2.28

Dividend / Share

$0.24

Dividend Yield

1.13%

52-Week High

$48.21

52-Week Low

$19.30

Volume

26,617

Avg Vol (3m)

35,748.603

Performance

+2.72%

-6.72%

-42.10%

-53.91%

YTD

-52.31%

-28.97%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

37.47

SMA (50)

$28.01

SMA (200)

$38.30

Price vs SMA50

-24.41%

Price vs SMA200

-44.72%

ATR (14)

$1.43

Financials

Revenue

$441M

Net Income

$10M

Gross Margin

64.4%

Operating Margin

7.6%

Net Margin

2.2%

Return on Equity

2.2%

Return on Assets

1.1%

Current Ratio

3.86

Debt / Equity

0.48

Revenue Growth (YoY)

+13.6%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.03	2026-05-08
FY 2025	$0.21	2026-02-18
Q3 2025	$0.16	2025-11-07
Q2 2025	$0.02	2025-08-08
Q1 2026	$-0.01	2026-05-08
FY 2025	$-0.32	2026-02-18

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

AORT vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers

105.23 / 28.73 med

+266% premium

P/S vs peers

2.33 / 2.52 med

-8% discount

Net margin vs peers

2.2% / -7.6% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.